SCHEMBL26115481

SCHEMBL26115481

COC(=O)c1cc(C)cc(-c2ccccc2C(=O)OC)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 5/20 0.56
▸ SLC6A4 P31645 3/20 0.56
▸ SLC6A2 P23975 1/20 0.56
▸ CNR2 P34972 3/20 0.49
▸ ROCK2 O75116 1/20 0.47
▸ CSF1R P07333 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ FLT3 P36888 1/20 0.47
▸ GSK3A P49840 1/20 0.47
▸ GSK3B P49841 1/20 0.47
▸ CDK5 Q00535 1/20 0.47
▸ ROCK1 Q13464 1/20 0.47
▸ SLK Q9H2G2 1/20 0.47
▸ IRAK4 Q9NWZ3 1/20 0.47
▸ TSHR P16473 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ CYP46A1 Q9Y6A2 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ CFTR P13569 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30571537 1.00 SLC6A3 (0.56) SLC6A3SLC6A4SLC6A2CNR2ROCK2
SCHEMBL19940155 0.84 SLC6A3 (0.55) SLC6A3SLC6A4SLC6A2CNR2ROCK2
SCHEMBL30285097 0.81 SLC6A3 (0.63) SLC6A3SLC6A4SLC6A2CNR2ROCK2
SCHEMBL7419776 0.81 CNR2 (0.46) SLC6A3SLC6A4SLC6A2CNR2TSHR
SCHEMBL7248274 0.81 TSHR (0.55) CNR2TSHRLMNAALDH1A1TDP1
SCHEMBL8249355 0.80 BCAT2 (0.54) SLC6A3SLC6A4SLC6A2ROCK2CSF1R
SCHEMBL68818 0.79 SLC6A3 (0.73) SLC6A3SLC6A4SLC6A2ROCK2CSF1R
SCHEMBL249 0.79 SLC6A3 (0.73) SLC6A3SLC6A4SLC6A2ROCK2CSF1R
SCHEMBL20936927 0.78 SLC6A3 (0.49) SLC6A3SLC6A4SLC6A2CNR2ROCK2
SCHEMBL30285287 0.77 SLC6A3 (0.71) SLC6A3SLC6A4SLC6A2ROCK2CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023183405-A2 PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS ALEXION PHARMACEUTICALS, INC. (US) 2023-09-28 — — WO disclosed
Send feedback